Fomivirsen clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
How each study uses fomivirsen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 26 Aug 1998 · VITRAVENE PRESERVATIVE FREE · NDA 020961 (FDA, Drugs@FDA)
- European Union
- 29 Jul 1999 · Vitravene · EMEA/H/C/000244 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Fomivirsen sodium
- 3
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses fomivirsen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the EyesCompletedNot applicableIonis Pharmaceuticals, Inc.NCT00002355Written as Fomivirsen sodium
- The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the EyesCompletedPhase 2Ionis Pharmaceuticals, Inc.NCT00002356Written as Fomivirsen sodium
- A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus RetinitisCompletedNot applicableIonis Pharmaceuticals, Inc.NCT00002187Written as Fomivirsen sodium
Codes
What other systems call fomivirsen · ClinicalTrials.gg INT003821
- MeSH (NLM) C091346fomivirsenConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) QX5LK7YCHVFOMIVIRSENConfirmed FDA, NLM, Wikidata
- RxNorm 85763One source FDA
- Wikidata Q104213687fomivirsenConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C174902FomivirsenOne source FDA
- DrugBank DB06759One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C091346 | fomivirsen | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | QX5LK7YCHV | FOMIVIRSEN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 85763 | — | One source FDA |
| Wikidata | Q104213687 | fomivirsen | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C174902 | Fomivirsen | One source FDA |
| DrugBank | DB06759 | — | One source Wikidata |
Also registered as fomivirsen sodium (UNII 3Z6W3S36X5 · RxNorm 314633).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.